Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers, and other healthcare services companies.
Gemma Game
GBX 4.89m as at 30-Apr-2013
|
Zurich Sterling AXA Framlington Health S2
|
|
|
|
|
|
Change (Mid)
1.00 (0.53%) 18-Jun-2013
|
|
06-Aug-2007
|
|
Zurich Sterling AXA Framlington Health
|
|
|
|
|
|
Change (Offer)
0.20 (0.59%) 18-Jun-2013
|
|
04-Dec-2000
|